3,7-dimethyl-1-propargylxanthine has been researched along with fluoxetine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaneko, S; Kawata, Y; Kondo, T; Mizuno, K; Murakami, T; Okada, M; Wada, K | 1 |
Brumand, K; Deemyad, T; Malihi, G; Pousti, A | 1 |
2 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and fluoxetine
Article | Year |
---|---|
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
Topics: Adenosine; Animals; Antihypertensive Agents; Biological Transport; Caffeine; Central Nervous System Stimulants; Fluoxetine; Hippocampus; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quipazine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Theobromine; Theophylline; Vasodilator Agents | 1999 |
Involvement of adenosine in the effect of fluoxetine on isolated guinea-pig atria.
Topics: Adenosine; Animals; Antidepressive Agents, Second-Generation; Depression, Chemical; Female; Fluoxetine; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines | 2006 |